Physician profile
Luyen D Pham
NPI 1518973759
$1,651.97
in general payments reported to CMS, 2019-2025
18 companies · $320 in 2025
The $320 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $47.79 · 2021: $184 · 2022: $346 · 2023: $297 · 2024: $311 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $281.46 | 2019-2025 | Bexsero, Pediarix, Penmenvy |
| Merck Sharp & Dohme LLC | $258.31 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Ironshore Pharmaceuticals INC. | $166.69 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $165.03 | 2019-2024 | |
| Corium, LLC | $130.10 | 2022-2024 | Azstarys |
| Sanofi-Aventis U.S. LLC | $105.84 | 2024-2025 | |
| Sanofi Pasteur INC. | $94.63 | 2019-2023 | |
| Cranial Technologies, INC | $77.08 | 2021-2025 | Doc Band |
| Kaleo, INC. | $67.32 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $51.46 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $45.92 | 2025 | Jornay Pm |
| Alk-Abello, INC | $45.67 | 2025 | Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $40.80 | 2020-2023 | Elaprase |
| Biomerieux INC | $31.00 | 2025 | |
| Seqirus USA INC | $27.79 | 2022-2025 | Flucelvax |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $25.88 | 2025 | Voxzogo 1.2mg |
| Nestle Healthcare Nutrition INC. | $21.49 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $15.50 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luyen Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.